CompletedNCT01921413
Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)
Studying Malaria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fyodor Biotechnologies Inc
- Principal Investigator
- Wellington A Oyibo, PhDANDI Centre of Excellence for Malaria Diagnosis, International Malaria Microscopy Training & RDT QA Center, & WHO/TDR/FIND Malaria Specimen Bank Site, Department of Medical Microbiology & Parasitology, College of Medicine, University of Lagos, Nigeria
- Intervention
- Urine Malaria Test(device)
- Enrollment
- 1893 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2013 – 2014
Study locations (1)
- College of Medicine of the University of Lagos, Idi Araba, Lagos, Nigeria
Collaborators
University of Lagos, Nigeria · Johns Hopkins University · Federal Ministry of Health, Nigeria · Duke University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01921413 on ClinicalTrials.govOther trials for Malaria
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07147400Pfs230D1 + R21 in Matrix-M1 in African School Children and AdultsSerum Institute of India Pvt. Ltd.
- RECRUITINGPHASE2NCT07036159A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsGlaxoSmithKline
- ACTIVE NOT RECRUITINGPHASE1NCT06735209First-in-Human PfSPZ-LARC2 Vaccination/CHMINational Institute of Allergy and Infectious Diseases (NIAID)
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06549257Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M AdjuvantUniversity of Oxford
- ACTIVE NOT RECRUITINGNANCT06599593Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and MalnutritionUniversity of California, San Francisco
- RECRUITINGPHASE4NCT06860178Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West AfricaEpicentre
- RECRUITINGPHASE3NCT06923592Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarLondon School of Hygiene and Tropical Medicine
- RECRUITINGPHASE3NCT07082205Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital DischargeLiverpool School of Tropical Medicine